Le Lézard
Classified in: Health
Subjects: CSR, PET, ANW

Help Animals Around the World on #GivingTuesday, Nov. 28, With Morris Animal Foundation


DENVER, Nov. 20, 2017 /PRNewswire/ -- From saving saigas in Mongolia to fighting cancer in dogs, Morris Animal Foundation is tackling the tough health issues facing animals around the world. On #GivingTuesday, November 28, animal lovers can help by making a gift to the Foundation to support its work.

Morris Animal Foundation Logo (PRNewsfoto/Morris Animal Foundation)

A gift to Morris Animal Foundation funds animal health studies including:

On #GivingTuesday 2016, animal lovers donated $20,000 to Morris Animal Foundation. This year, the goal is $25,000 to help fund studies that will advance animal health. #GivingTuesday gifts also will be matched dollar for dollar by generous donors (up to $217,000) as part of the Foundation's end-of-year giving campaign.

"If you have a pet, your life has been impacted by health studies funded by Morris Animal Foundation," said Dr. John Reddington, President and CEO of Morris Animal Foundation. "We work every day to help ensure the animals we all love, in our homes and in the wild, have the healthiest lives possible. But we can't do it without the support of generous donors."

#GivingTuesday is held annually on the Tuesday after Thanksgiving. The giving day kicks off the holiday giving season and inspires people to collaborate in improving their local, national and global communities and to give back in impactful ways to the charities and causes they support. Make your gift today at Morris Animal Foundation #GivingTuesday.

About Morris Animal Foundation

Established in 1948, Morris Animal Foundation is dedicated to improving and protecting the health of animals through scientific innovation, education and inspiration. Our investment in research has yielded life-saving vaccines, new treatments for critical diseases, superior screening tests, and advanced diagnostic tools. We respond to emerging animal health threats that endanger entire species, and make new discoveries in basic animal biology to support applied research. With every study we fund ? more than 2,600 to date ? we strive to advance the science of veterinary medicine, honoring the founding principles of Dr. Mark L. Morris Sr. to benefit animals worldwide. Learn more at morrisanimalfoundation.org

 

SOURCE Morris Animal Foundation


These press releases may also interest you

at 11:43
Bulletin from annual general meeting of Enzymatica AB (publ) on May 7, 2024
Enzymatica AB (publ) held its annual general meeting on May 7, 2024. At the annual general meeting, the following resolutions were made. Income statements and balance sheets The general meeting resolved to adopt the income statement and the balance...

at 11:31
Public Advisory - Health Canada warns about multiple unauthorized sexual enhancement products that may pose serious health risks
Health Canada is advising that the following product(s) may pose serious health risks. For more information, including product photos and what you should do, visit these online safety alerts: Unauthorized sexual enhancement productsHealth Canada...

at 11:30
Philips shareholders approve all proposals at the AGM 2024
May 7, 2024 Amsterdam, the Netherlands ? Royal Philips , today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, including: The re-appointment of Chairman...

at 11:25
NovAccess Global Advisory on Annual Meeting of Shareholders
NovAccess Global Inc. , a biomedical company developing novel immunotherapies for brain tumor patients, today announced the postponement of its Annual Meeting of Shareholder which was previously scheduled to be held in May 2024. The Company expects...

at 11:20
NIH Awards Hesperos Research Grant to Develop Animal-Free Botox Testing Platform
Hesperos, a leader in emulating human biology for drug discovery, was awarded a $2 million research grant by the National Center for Advancing Translational Sciences (NCATS) in collaboration with the U.S. Food and Drug Administration (FDA). The goal...

at 11:16
Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak
Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") today confirmed that it has received a revised unsolicited proposal from Future Pak, LLC ("Future Pak") to acquire the Company. The revised proposal consists of a $7.25 to $7.75 per share in cash...

More news about Health...


News published on and distributed by: